Active

T1D Fund

General contacts
Investor type

VC / Fund of funds

Founded

2016

AUM

$250 M

Location

Boston, Massachusetts, United States

Investment Ticket

$10-50 m

Investment Stage

Series A Seed Pre-seed Series B

Region of investment

Europe North America Asia

ESG Focus

Impact investor
Investor profile last updated: 14 September, 2026

Profile

T1D Fund is a venture fund dedicated to catalyzing the development of therapies for Type 1 Diabetes (T1D). Based in Boston, the fund was launched in 2016 as a wholly owned subsidiary of Breakthrough T1D. The team consists of experienced professionals from venture capital, investment banking, pharma, and company building sectors. Their unique approach is focused on accelerating treatments and eventual cures for T1D through strategic investments and partnerships with biopharmaceutical companies and venture capital firms.

The fund primarily invests in early-stage biotech companies working on disease-modifying therapies and potential cures for T1D. With over $250 million in assets under management, they reinvest all returns back into new investments, maintaining a cycle aimed at fueling foundational research and therapeutic development. T1D Fund's unique positioning allows it to de-risk investments and attract further interest in the T1D space.

Notable companies in their portfolio include Zag Bio, which focuses on thymus-targeted medicines for autoimmune diseases, and Zucara Therapeutics, working on diabetes life sciences. By leveraging its vast clinical, regulatory, and medical network, T1D Fund strives to rapidly advance the development of these promising therapies.

Industry

Life Sciences MedTech Pharmaceuticals Medical Devices Healthcare Services Biotechnology HealthTech Technology

T1D Fund Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region 		Size AUM Launch date
T1D Fund
Venture Capital (VC)
Biotechnology
Medical Devices
Technology
Life Sciences
Pre-seed
Seed
North America
$5-10 m
$200 M
December 2016

Contacts

Name
Title
Email
Social Networks
avatar
Daniel Flicker Principal
Principal
d•••@•••
LinkedIn
avatar
Lucio Iannone Managing Director
Managing Director
l•••@•••
LinkedIn
Upgrade to see contacts
avatar
doQuiwnON7Y2XBH3 doQuiwnON7Y2XBH3
doQuiwnON7Y2XBH3
[email protected]
linkedin twitter
avatar
doQuiwnON7Y2XBH3 doQuiwnON7Y2XBH3
doQuiwnON7Y2XBH3
[email protected]
linkedin twitter
avatar
doQuiwnON7Y2XBH3 doQuiwnON7Y2XBH3
doQuiwnON7Y2XBH3
[email protected]
linkedin twitter
Investment-team contacts for T1D Fund — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about T1D Fund

T1D Fund is a venture capital firm that also operates as a fund of funds. It backs companies at Series A, Seed, Pre-seed and Series B, writing tickets of $10-50 m.
T1D Fund is located in Boston, Massachusetts, United States.
T1D Fund was founded in 2016.
T1D Fund invests in companies and startups in Life Sciences, MedTech, Pharmaceuticals, Medical Devices, Healthcare Services, Biotechnology, HealthTech, Technology.
T1D Fund invests in companies and startups in Europe, North America, Asia.
T1D Fund invests in companies and startups at Series A, Seed, Pre-seed, Series B.
T1D Fund usually invests $10-50 m on average.
T1D Fund has around $250m assets under management.
T1D Fund last fund was created/launched in 2026-04-13
Yes, T1D Fund is impact investor.
T1D Fund can be reached through its website t1dfund.org, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for T1D Fund — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query T1D Fund directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 14 September, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.